Solutions for Pharmaceutical

Structured digital products built to identify technical gaps in formulation, process, and CMC strategy.

Encrypted Intelligence Solutions for Asset Protection

Asset Risk Intelligence Report

Our core solution is a deeply researched digital assessment tailored to your specific asset and milestone objective.

Each report evaluates:

Dosage form feasibility and stability considerations
Chemistry and formulation risk factors
Process development vulnerabilities
CMC documentation alignment
Manufacturing scale-up exposure
Regulatory positioning gaps

Milestone-Specific Risk Review

Funding events, diligence reviews, and regulatory submissions require defensible technical positioning.

We assess how formulation, process, and CMC strategy align with your upcoming milestone, helping reduce the risk of:

Unexpected capital requirements
Delayed regulatory feedback
Investor scrutiny
Legal exposure

Encrypted Delivery Model

All exchanges occur exclusively through end-to-end encrypted file sharing using Tresorit.

We do not conduct live consulting sessions.
We do not engage through unsecured communication.
We do not begin asset discussions without an executed NDA.
All content is created by human expertise.
No client data is entered into AI systems.
Written assurance is available upon engagement.
Deliverables are accessed securely through controlled cloud permissions.

Technical Brief Downloads

We provide high-level downloadable briefs outlining our evaluation framework.

Expanded documentation and deeper technical materials become available after NDA execution.

This structure protects both parties while allowing you to assess alignment.

Our Confidential Approach

Protect your sensitive information with our encrypted process—starting with a signed NDA and secure platform access. Reach out for a confidential assessment today.

Connect With Us